Region:  
 
      Advanced
Search
 
Bookmark and Share 
  
Find An Educational Offering
Select Search Criteria
Keyword:
Events starting on or after:  mm/dd/yyyy
Events Added:
Region:
Interest Areas (IA): Hold the CTRL key to select or de-select multiple items from adjacent list box

     
Event Type: Hold the CTRL key to select or de-select multiple items from adjacent list box

 
 
  Click here to Expand the Tab 
10025 Global Approach to the Risk Management of Medicines
 Overview 
 Agenda / Committee 
 Continuing Education 
 Tutorial / Sub-Events 
 Exhibits 
 Travel/Hotel Information 
 Registration Fees 
 Related Offerings 
 Highlights 
Title:
Global Approach to the Risk Management of Medicines


Date(s) And Time(s):
Sep 30 2010 8:00AM - Oct 1 2010 4:00PM

Location:
Washington Marriott Hotel
1221 22nd Street NW
Washington, DC 20037-1294 

Overview:

Join Authorities, Global Regulators, Industry Representatives, and Marketing Application Holders for an Interactive Discussion of RMPS.

This conference will teach you how to identify and organize essential components of RMPs as they apply to medicinal products, therapeutic biologics, and vaccines. Experts speakers will focus on well-described risks, poorly understood risks, and certain potential risks of products, which may be made available to patients and healthcare providers in different regions of the world.

Featured Topics
• Why risk management plans (RMPs) are important to your organization from a global regulatory perspective
• Pros and cons of a global vs. local approach to developing RMPs
• How an harmonized RMP can promote efficient, evidence-based decision-making to support the best use of marketed products and thereby enhance public health
• How to develop an harmonized approach to creating an RMP



Learning Objectives:
At the conclusion of this meeting, participants should be able to:
• Discuss the fundamental aspects of RMPs as applied to medicinal products, therapeutic biologics, and vaccines
• Recognize similarities and differences in RMP requirements in several regulatory jurisdictions, including Canada, the European Economic Area, Japan, and the US
• Discuss the role of RMPs from the perspective of marketing authorization holders, regulatory authorities, and other stakeholders


Target Audience:
Professionals with a basic to intermediate experience in pharmacovigilance and risk management and who are responsible for:
• Developing and evaluating RMPs
• Generating and assessing drug safety signals
• Organizing post-authorization safety studies


Event Code:
10025

Contact Information:

Contact JoAnn Boileau, Program Manager, Phone +1.215.442.6175, Fax +1.215.442.6199, or email JoAnn.Boileau@diahome.org